PNOC 019: A Randomized, Double-Blinded, Pilot Trial of Neoadjuvant Checkpoint Inhibition followed by Combination Adjuvant Checkpoint Inhibition in Children and Young Adults with Recurrent or Progressive High Grade Glioma (HGG)
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
The Regents of the University of California
Start Date
November 24, 2021
End Date
September 30, 2026
Administered By
Duke Cancer Institute
Awarded By
The Regents of the University of California
Start Date
November 24, 2021
End Date
September 30, 2026